G.R. Pinto, C.A. Clara, M.J. Santos, J.R.W. Almeida, R.R. Burbano,J.A. Rey, C. Casartell
Published November 27, 2007
Genet. Mol. Res. 6 (4): 1019-1025 (2007)

About the authors
G.R. Pinto, C.A. Clara, M.J. Santos, J.R.W. Almeida, R.R. Burbano,J.A. Rey, C. Casartell

Corresponding author
G.R. Pinto
E-mail: pintogr@gmail.com

ABSTRACT

Gliomas are the most common tumors of the central nervous system. In spite of the marked advances in the characterization of the molecular pathogenesis of gliomas, these tumors remain incurable and, in most of the cases, resistant to treatments, due to their molecular heterogeneity. Gene PAX6, which encodes a transcription factor that plays an important role in the development of the central nervous system, was recently recognized as a tumor suppressor in gliomas. The objective of the present study was to analyze the mutational status of the coding and regulating regions of PAX6 in 94 gliomas: 81 astrocytomas (11 grade I, 23 grade II, 8 grade III, and 39 grade IV glioblastomas), 5 oligodendrogliomas (3 grade II, and 2 grade III), and 8 ependymomas (5 grade II, and 3 grade III). Two regulating regions (SX250 and EIE) and the 11 coding regions (exons 4-13, plus exon 5a resulting from alternative splicing) of gene PAX6 were analyzed and no mutation was found. Therefore, we conclude that the tumor suppressor role of PAX6, reported in previous studieson gliomas, is not due to mutation in its coding and regulating regions, suggesting the involvement of epigenetic mechanisms in the silencing of PAX6 in these tumors.

Key words: Mutation, PAX6, Gliomas